Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi‐Based Immunochemotherapy of Intracranial Glioblastoma Treatment

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Materials

• Publication date

  2018-05-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1002/adma.201705054PMID 29577457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors

  2017cited by this paper
• Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy

  2017cited by this paper
• Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.

  2017cited by this paper
• H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay

  2017cited by this paper
• Metal–organic framework with optimally selective xenon adsorption and separation

  2016cited by this paper
• Traceable Nanoparticle Delivery of Small Interfering RNA and Retinoic Acid with Temporally Release Ability to Control Neural Stem Cell Differentiation for Alzheimer's Disease Therapy

  2016cited by this paper
• Fusogenic Reactive Oxygen Species Triggered Charge‐Reversal Vector for Effective Gene Delivery

  2016cited by this paper
• External Magnetic Field-Induced Targeted Delivery of Highly Sensitive Iron Oxide Nanocubes for MRI of Myocardial Infarction.

  2016cited by this paper
• Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.

  2016cited by this paper
• Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.

  2016cited by this paper
• Comparative and parallel genome-wide association studies for metabolic and agronomic traits in cereals

  2016cited by this paper
• Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line

  2015cited by this paper
• Zwitterionic Poly(carboxybetaine)-based Cationic Liposomes for Effective Delivery of Small Interfering RNA Therapeutics without Accelerated Blood Clearance Phenomenon

  2015cited by this paper
• Near-Infrared-Activated Nanocalorifiers in Microcapsules: Vapor Bubble Generation for In Vivo Enhanced Cancer Therapy.

  2015cited by this paper
• Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy

  2015cited by this paper
• Toward an effective strategy in glioblastoma treatment. Part II: RNA interference as a promising way to sensitize glioblastomas to temozolomide.

  2015cited by this paper
• Rational assembly of a biointerfaced core@shell nanocomplex towards selective and highly efficient synergistic photothermal/photodynamic therapy.

  2015cited by this paper
• Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.

  2015cited by this paper
• Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.

  2014cited by this paper
• Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.

  2014cited by this paper
• Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

  2014cited by this paper
• Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment

  2014cited by this paper
• Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma.

  2014cited by this paper
• A Broad Nanoparticle-Based Strategy for Tumor Imaging by Nonlinear Amplification of Microenvironment Signals

  2013cited by this paper
• TGF-β as a therapeutic target in high grade gliomas - promises and challenges.

  2013cited by this paper
• Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.

  2012cited by this paper
• Multistage pH‐Responsive Liposomes for Mitochondrial‐Targeted Anticancer Drug Delivery

  2012cited by this paper
• In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.

  2011cited by this paper
• Current concepts and management of glioblastoma

  2011cited by this paper
• Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

  2011cited by this paper
• Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.

  2011cited by this paper
• Mechanisms of immunomodulation in human glioblastoma.

  2011cited by this paper
• A Brain Tumor Molecular Imaging Strategy Using A New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle

  2011cited by this paper
• Experimental approaches for the treatment of malignant gliomas.

  2010cited by this paper
• Scale to predict survival after surgery for recurrent glioblastoma multiforme.

  2010cited by this paper
• Mechanisms of local immunoresistance in glioma.

  2010cited by this paper
• Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

  2010cited by this paper
• Investigation of immunosuppressive mechanisms in a mouse glioma model

  2009cited by this paper
• Therapeutic targets in malignant glioblastoma microenvironment.

  2009cited by this paper
• Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

  2009cited by this paper
• Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.

  2007cited by this paper

• Recent advances in nanoparticles targeting TGF-β signaling for cancer treatment

  2026cites this paper
• Overcoming intranasal delivery barriers with ultrastable polyzwitterionic siRNA nanocages for enhanced glioblastoma therapy

  2026cites this paper
• Precision nanomedicine in cardiovascular disease: Engineered siRNA delivery platforms for atherosclerosis and ischemic heart disease

  2026cites this paper
• Recent advances in biomimetic nanodelivery systems for the treatment of glioblastoma.

  2025cites this paper
• Multifunctional nanoplatforms based on RNA interference for glioma treatment.

  2025cites this paper
• Zwitterionic lipid nanoparticles for efficient siRNA delivery and hypercholesterolemia therapy with rational charge self-transformation

  2025cites this paper
• Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies

  2025cites this paper
• Advanced nanoparticle engineering for precision therapeutics of brain diseases.

  2025cites this paper
• Oncolytic Virus Targeted Therapy for Glioma via Intravenous Delivery

  2025cites this paper
• Advanced Carriers for Precise Delivery and Therapeutic Mechanisms of Traditional Chinese Medicines: Integrating Spatial Multi‐Omics and Delivery Visualization

  2025cites this paper
• Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy

  2025cites this paper
• Polycarboxybetaine in advanced drug delivery systems: From structure-function relationship to therapeutic applications

  2025cites this paper
• Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma.

  2024cites this paper
• Hydrogen sulfide-generating semiconducting polymer nanoparticles for amplified radiodynamic-ferroptosis therapy of orthotopic glioblastoma.

  2024cites this paper
• Nanotechnology in Glioblastoma Therapy: Advances in Drug Delivery Systems and Diagnostic Approaches

  2024cites this paper
• Advances and prospects of RNA delivery nanoplatforms for cancer therapy

  2024cites this paper
• Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases.

  2024cites this paper
• Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted Nano-delivery technology.

  2024cites this paper
• Advancements in dendrimer-based drug delivery for combinatorial cancer therapy

  2024cites this paper
• Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma

  2024cites this paper
• Dual‐Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy

  2024cites this paper
• Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation

  2024cites this paper
• Chondroitin Sulfate-Derived Micelles for Adipose Tissue-Targeted Delivery of Celastrol and Phenformin to Enhance Obesity Treatment.

  2024cites this paper
• Nucleic acid drug vectors for diagnosis and treatment of brain diseases

  2023cites this paper
• Nanotechnology-enabled therapies improve blood-brain barrier challenges in brain tumor

  2023cites this paper
• Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases

  2023cites this paper
• Enhanced Nose-to-Brain Delivery of Combined Small Interfering RNAs Using Lesion-Recognizing Nanoparticles for the Synergistic Therapy of Alzheimer's Disease.

  2023cites this paper
• Engineered bacterial extracellular vesicles for central nervous system diseases.

  2023cites this paper
• Synthetic High-Density Lipoprotein-Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma.

  2023cites this paper
• Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy.

  2023cites this paper
• Engineering blood-brain barrier-permeable and tumor cell-ingestible pro-proteins for glioblastoma treatment

  2023cites this paper
• Nano-engineering nanomedicines with customized functions for tumor treatment applications

  2023cites this paper
• Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study

  2023cites this paper
• Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: In Vitro and In Vivo Effects of PEGylation in the Management of Glioblastoma Multiforme.

  2023cites this paper
• Emerging Nano‐Immunotherapeutic Approaches to Glioma

  2023cites this paper
• Nucleic acid delivery by ionizable nanocarriers for brain disease treatment

  2023cites this paper
• Non-viral nucleic acid delivery approach: A boon for state-of-the-art gene delivery

  2023cites this paper
• A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma

  2023cites this paper
• A STIR nucleic acid drug delivery system for stirring phenotypic switch of microglia in Parkinson’s disease treatments

  2023cites this paper
• Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma.

  2023cites this paper
• Screening of Zwitterionic Liposomes with Red Blood Cell‐Hitchhiking and Tumor Cell‐Active Transporting Capability for Efficient Tumor Entrance

  2023cites this paper
• Engineered drug delivery nanosystems for tumor microenvironment normalization therapy

  2023cites this paper
• Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders

  2023cites this paper
• Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma

  2022cites this paper
• Charge reversal nano-systems for tumor therapy

  2022cites this paper
• A review of recent advances in magnetic nanoparticle-based theranostics of glioblastoma.

  2022cites this paper
• Codelivery of Shikonin and siTGF-β for enhanced triple negative breast cancer chemo-immunotherapy.

  2022cites this paper
• RNA cancer nanomedicine: nanotechnology-mediated RNA therapy.

  2022cites this paper
• Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article)

  2022cites this paper
• Nanomedicine for Brain Cancer.

  2022cites this paper
• Implication of Nanomedicine in Therapy of Oxidative Stress-Induced Cancer

  2022cites this paper
• Engineering 2D Cu-composed metal–organic framework nanosheets for augmented nanocatalytic tumor therapy

  2022cites this paper
• Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy.

  2022cites this paper
• RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics

  2022cites this paper
• Rational design of ROS-responsive nanocarriers for targeted X-ray-induced photodynamic therapy and cascaded chemotherapy of intracranial glioblastoma.

  2022cites this paper
• Shape‐Mediated Magnetocrystalline Anisotropy and Relaxation Controls by Cobalt Ferrite Core–Shell Heterostructures for Magnetothermal Penetration Delivery

  2022cites this paper
• Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy

  2022cites this paper
• Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy

  2022cites this paper
• Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives

  2022cites this paper
• Biomaterial-enhanced cancer vaccines

  2022cites this paper
• Prevent Drug Leakage via the Boronic Acid Glucose-Insensitive Micelle for Alzheimer's Disease Combination Treatment.

  2022cites this paper
• Brain-targeting drug delivery systems.

  2022cites this paper
• Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases.

  2022cites this paper
• Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy

  2022cites this paper
• An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity

  2022cites this paper
• An update on dual targeting strategy for cancer treatment.

  2022cites this paper
• Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery

  2022cites this paper
• Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy

  2022cites this paper
• Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy

  2022cites this paper
• Transcytosis-enabled active extravasation of tumor nanomedicine.

  2022cites this paper
• Nucleic acid-based therapy for brain tumor: Challenges and strategies.

  2022cites this paper
• Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable

  2022cites this paper
• Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy

  2022cites this paper
• Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy

  2022cites this paper
• Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions.

  2022cites this paper
• Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

  2022cites this paper
• Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis

  2022cites this paper
• Multifunctional nanomedicine strategies to manage brain diseases

  2022cites this paper
• Transformable Nanotheranostics Capable of Sensoring Nucleic Acid Drugs’ Spatiotemporal Behaviors

  2022cites this paper
• A Biologically Compatible Colorimetric Sensor for the Selective Recognition of Cu 2+ Ions in Biological Matrices

  2022cites this paper
• The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma

  2022cites this paper
• Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice

  2021cites this paper
• The current and future aspects of glioblastoma: Immunotherapy a new hope?

  2021influential citation
• Overcoming delivery barriers in immunotherapy for glioblastoma

  2021cites this paper
• Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release

  2021cites this paper
• Construction of nanomaterials as contrast agents or probes for glioma imaging

  2021cites this paper
• Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy

  2021cites this paper
• MRI-traceable theranostic nanoparticles for targeted cancer treatment

  2021cites this paper
• siRNA-Based Carrier-Free System for Synergistic Chemo/Chemodynamic/RNAi Therapy of Drug-Resistant Tumors.

  2021cites this paper
• High expression of TXNDC11 indicated unfavorable prognosis of glioma

  2021cites this paper
• Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects

  2021cites this paper
• Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma

  2021cites this paper
• Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics

  2021influential citation
• Implication of Nanomedicine in Therapy of Oxidative Stress Induced Cancer

  2021cites this paper
• Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases.

  2021cites this paper
• Smart Biomaterials to Enhance the Efficiency of Immunotherapy in Glioblastoma: State of the Art and Future Perspectives.

  2021cites this paper
• Cation‐Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy

  2021cites this paper
• Modular design of multifunctional core-shell tecto dendrimers complexed with copper(II) for MR imaging-guided chemodynamic therapy of orthotopic glioma

  2021cites this paper
• Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.

  2021cites this paper
• Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas

  2021cites this paper